ClinicalTrials.Veeva

Menu

Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Unknown
Phase 4

Conditions

Functional Constipation
Chronic Idiopathic Constipation

Treatments

Procedure: Anal Myectomy
Drug: Botulinum Toxin

Study type

Interventional

Funder types

Other

Identifiers

NCT02361749
CAIUNIPEDSURG-CR2
PACTR201408000857349 (Other Identifier)

Details and patient eligibility

About

Chronic idiopathic constipation is most common cause of Constipation in childhood with numerous cases in Egypt. Numerous conservative measures were tried but many fail. Surgical options include Longitudinal Myectomy of the muscle or injection of Botulinum toxin. Objectives: Comparative study between Botulinum toxin injection and Myectomy in treatment of Idiopathic Constipation

Full description

Functional constipation (chronic idiopathic constipation) is most common cause of constipation in pediatric age group. Many cases try conservative treatment but fail to respond. These cases are treated by surgical longitudinal myectomy of the anal sphincter. Now, there have been many trials of trying injection of botulinum toxin to relax the sphincter as a treatment of functional/idiopathic constipation.

In this study, the investigators will compare the results of botulinum toxin injection versus surgical myectomy to treat functional/idiopathic constipation in children.

Enrollment

40 estimated patients

Sex

All

Ages

2 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Children with Idiopathic constipation

Exclusion criteria

  • Hirschsprung's disease or Anorectal malformations

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

40 participants in 2 patient groups

Myectomy group
Active Comparator group
Description:
Subjects will undergo anal myectomy for their anal sphincter.
Treatment:
Procedure: Anal Myectomy
Botox Group
Active Comparator group
Description:
Subjects will undergo Botulinum toxin injection into their anal sphincter.
Treatment:
Drug: Botulinum Toxin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems